CN118267508B - Metal-based composite antibacterial liquid and preparation method and application thereof - Google Patents
Metal-based composite antibacterial liquid and preparation method and application thereof Download PDFInfo
- Publication number
- CN118267508B CN118267508B CN202410641845.2A CN202410641845A CN118267508B CN 118267508 B CN118267508 B CN 118267508B CN 202410641845 A CN202410641845 A CN 202410641845A CN 118267508 B CN118267508 B CN 118267508B
- Authority
- CN
- China
- Prior art keywords
- rare earth
- solution
- chitosan
- metal
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 83
- 229910052751 metal Inorganic materials 0.000 title claims abstract description 71
- 239000002184 metal Substances 0.000 title claims abstract description 71
- 239000007788 liquid Substances 0.000 title claims abstract description 54
- 239000002131 composite material Substances 0.000 title claims abstract description 48
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 229920001661 Chitosan Polymers 0.000 claims abstract description 103
- 229910052761 rare earth metal Inorganic materials 0.000 claims abstract description 89
- 150000002910 rare earth metals Chemical class 0.000 claims abstract description 59
- 229920000642 polymer Polymers 0.000 claims abstract description 53
- 239000002070 nanowire Substances 0.000 claims abstract description 49
- 239000006185 dispersion Substances 0.000 claims abstract description 21
- 239000002904 solvent Substances 0.000 claims abstract description 6
- 239000000243 solution Substances 0.000 claims description 105
- -1 rare earth salt Chemical class 0.000 claims description 41
- 238000003756 stirring Methods 0.000 claims description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 22
- 239000002033 PVDF binder Substances 0.000 claims description 19
- 229920002981 polyvinylidene fluoride Polymers 0.000 claims description 19
- 239000007864 aqueous solution Substances 0.000 claims description 18
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 18
- 239000012266 salt solution Substances 0.000 claims description 18
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 14
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 14
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 14
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 8
- 239000002042 Silver nanowire Substances 0.000 claims description 8
- 239000011248 coating agent Substances 0.000 claims description 8
- 238000000576 coating method Methods 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- 229910052802 copper Inorganic materials 0.000 claims description 7
- 239000010949 copper Substances 0.000 claims description 7
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 4
- 239000011701 zinc Substances 0.000 claims description 4
- 229910052725 zinc Inorganic materials 0.000 claims description 4
- 239000011156 metal matrix composite Substances 0.000 claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 2
- 229910052684 Cerium Inorganic materials 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 2
- 229910052693 Europium Inorganic materials 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 229910052772 Samarium Inorganic materials 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 2
- 150000001450 anions Chemical class 0.000 claims description 2
- 150000001768 cations Chemical class 0.000 claims description 2
- 239000004584 polyacrylic acid Substances 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 229910052727 yttrium Inorganic materials 0.000 claims description 2
- 230000002421 anti-septic effect Effects 0.000 claims 3
- 229910002651 NO3 Inorganic materials 0.000 claims 1
- 229910052779 Neodymium Inorganic materials 0.000 claims 1
- 229910052746 lanthanum Inorganic materials 0.000 claims 1
- 235000015424 sodium Nutrition 0.000 claims 1
- 230000032683 aging Effects 0.000 abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 230000000052 comparative effect Effects 0.000 description 14
- HSJPMRKMPBAUAU-UHFFFAOYSA-N cerium(3+);trinitrate Chemical compound [Ce+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O HSJPMRKMPBAUAU-UHFFFAOYSA-N 0.000 description 8
- HZYQDGWUPIXLGL-UHFFFAOYSA-N cerium silver Chemical compound [Ag].[Ag].[Ce] HZYQDGWUPIXLGL-UHFFFAOYSA-N 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- NGDQQLAVJWUYSF-UHFFFAOYSA-N 4-methyl-2-phenyl-1,3-thiazole-5-sulfonyl chloride Chemical compound S1C(S(Cl)(=O)=O)=C(C)N=C1C1=CC=CC=C1 NGDQQLAVJWUYSF-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- KQJQGYQIHVYKTF-UHFFFAOYSA-N cerium(3+);trinitrate;hydrate Chemical compound O.[Ce+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O KQJQGYQIHVYKTF-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000013068 control sample Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- GAGGCOKRLXYWIV-UHFFFAOYSA-N europium(3+);trinitrate Chemical compound [Eu+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O GAGGCOKRLXYWIV-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- CFYGEIAZMVFFDE-UHFFFAOYSA-N neodymium(3+);trinitrate Chemical compound [Nd+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O CFYGEIAZMVFFDE-UHFFFAOYSA-N 0.000 description 2
- YZDZYSPAJSPJQJ-UHFFFAOYSA-N samarium(3+);trinitrate Chemical compound [Sm+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O YZDZYSPAJSPJQJ-UHFFFAOYSA-N 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 244000208060 Lawsonia inermis Species 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- MQIMWMYRKISISJ-UHFFFAOYSA-N O.[Sm+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O Chemical compound O.[Sm+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O MQIMWMYRKISISJ-UHFFFAOYSA-N 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- LDPKCXKLTNSWAB-UHFFFAOYSA-N [Zn].[Sm] Chemical compound [Zn].[Sm] LDPKCXKLTNSWAB-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- GBAOZECSOKXKEL-UHFFFAOYSA-N copper yttrium Chemical compound [Cu].[Y] GBAOZECSOKXKEL-UHFFFAOYSA-N 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000006196 deacetylation Effects 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- RSLVUJIBUHMFNL-UHFFFAOYSA-N europium silver Chemical compound [Ag].[Ag].[Ag].[Ag].[Ag].[Eu] RSLVUJIBUHMFNL-UHFFFAOYSA-N 0.000 description 1
- XLGOHVJDOSTECY-UHFFFAOYSA-N europium(3+);trinitrate;hydrate Chemical compound O.[Eu+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O XLGOHVJDOSTECY-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- CZMAIROVPAYCMU-UHFFFAOYSA-N lanthanum(3+) Chemical compound [La+3] CZMAIROVPAYCMU-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000002082 metal nanoparticle Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- QEFYFXOXNSNQGX-UHFFFAOYSA-N neodymium atom Chemical compound [Nd] QEFYFXOXNSNQGX-UHFFFAOYSA-N 0.000 description 1
- CRLLGLJOPXYTLX-UHFFFAOYSA-N neodymium silver Chemical compound [Ag].[Nd] CRLLGLJOPXYTLX-UHFFFAOYSA-N 0.000 description 1
- GZIAUVGSMHERLN-UHFFFAOYSA-N neodymium(3+);trinitrate;hydrate Chemical compound O.[Nd+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O GZIAUVGSMHERLN-UHFFFAOYSA-N 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- WUVRZBFIXJWTGS-UHFFFAOYSA-N yttrium(3+);trinitrate;hydrate Chemical compound O.[Y+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O WUVRZBFIXJWTGS-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/08—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
- A01N25/10—Macromolecular compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/14—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
- A01N43/16—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/16—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A61L2300/104—Silver, e.g. silver sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Pest Control & Pesticides (AREA)
- Environmental Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Materials For Medical Uses (AREA)
Abstract
The invention provides a metal-based composite antibacterial liquid, a preparation method and application thereof, wherein the metal-based composite antibacterial liquid is prepared from polymer-coated metal nanowire dispersion liquid, polymer-coated chitosan rare earth complex solution and a solvent, the content of metal nanowires in the metal-based composite antibacterial liquid is 3-30mg/L, and the concentration of chitosan rare earth complex in the metal-based composite antibacterial liquid is 0.00001-0.0005mol/L. The metal-based composite antibacterial liquid has excellent antibacterial performance, long-acting antibacterial performance and excellent ageing resistance.
Description
Technical Field
The invention belongs to the field of antibacterial materials, and particularly relates to a metal matrix composite antibacterial liquid, and a preparation method and application thereof.
Background
At present, the antibacterial liquid which can be directly sprayed on the surface of an object mostly adopts an organic antibacterial agent as an active ingredient, and the organic antibacterial agent has extremely high antibacterial and bacteriostatic efficiency, but has poor ageing resistance, and can realize sustainable antibacterial by a frequent spraying method, so that the use cost is indirectly increased; meanwhile, silver and copper nano-particles are used as antibacterial active ingredients, but the silver and copper nano-particles are easy to color and have higher cost.
According to the invention, the polymer-coated metal nanowire is adopted, the risk of color change of the metal nanowire can be avoided through polymer coating, an antibacterial network with a positive large surface can be formed through the mutual intersection of the nanowires, meanwhile, rare earth has excellent antibacterial performance, and the rare earth has extremely outstanding ageing resistance, high temperature resistance and long-acting property, so that the metal nanowire is matched with the rare earth complex to prepare the antibacterial liquid with low cost, environmental protection, low carbon, excellent antibacterial effect and excellent long-acting property.
Disclosure of Invention
In view of the above, the present invention aims to overcome the defects in the prior art, and provides a metal matrix composite antibacterial liquid, and a preparation method and application thereof.
In order to achieve the above purpose, the technical scheme of the invention is realized as follows:
In a first aspect, the invention provides a metal-based composite antibacterial solution, which is prepared from polymer-coated metal nanowire dispersion liquid, polymer-coated chitosan rare earth complex solution and a solvent, wherein the content of metal nanowires in the metal-based composite antibacterial solution is 3-30mg/L, and the concentration of chitosan rare earth complex in the metal-based composite antibacterial solution is 0.00001-0.0005mol/L.
Preferably, the polymer is one or a combination of at least two of polyvinylpyrrolidone (PVP), hydroxypropyl cellulose, sodium hydroxypropyl cellulose, polyvinylidene fluoride (PVDF), polyacrylic acid.
Preferably, the metal nanowire is one or a combination of at least two of silver nanowire, copper nanowire and zinc nanowire.
Preferably, the chitosan rare earth complex is synthesized by reacting rare earth salt with chitosan or chitosan quaternary ammonium salt.
Preferably, the cation of the rare earth salt comprises any one or a combination of at least two of cerium ion, lanthanum ion, yttrium ion, samarium ion, europium ion or neodymium ion.
Preferably, the anion of the rare earth salt is any one or a combination of at least two of nitrate ion, chloride ion, sulfate ion or acetate ion.
Preferably, the solvent is ethanol and/or water.
Preferably, the preparation method of the polymer-coated metal nanowire dispersion liquid comprises the following steps:
dissolving a polymer in water to obtain a polymer water solution A, adding the metal nanowire into the polymer water solution A, and stirring for 0.5-4h at the rotating speed of 50-500 rad/min to obtain a polymer coated metal nanowire dispersion.
Preferably, the concentration of the metal nanowires in the polymer-coated metal nanowire dispersion is 1-10g/L.
Preferably, the mass concentration of the polymer aqueous solution A is 0.5% -5%.
Preferably, the preparation method of the polymer-coated chitosan rare earth complex solution comprises the following steps:
S1: dispersing chitosan or chitosan quaternary ammonium salt in pure water, heating to 50-80 ℃, and stirring for 0.1-2h at a rotating speed of 50-500rad/min to obtain chitosan solution;
s2: dissolving rare earth salt hydrate in pure water to prepare rare earth salt solution;
S3: dropwise adding the rare earth salt solution into the chitosan solution, and stirring for 0.5-4h at 50-80 ℃ under vacuum condition to obtain chitosan rare earth complex solution;
s4: and (3) dropwise adding the chitosan rare earth complex solution into the polymer aqueous solution B, and stirring for 10-60min at normal temperature to obtain the polymer-coated chitosan rare earth complex solution.
Preferably, the concentration of the chitosan solution prepared in the step S1 is 0.05-0.3mol/L.
Preferably, the concentration of the rare earth salt solution prepared in the step S2 is 0.3-0.8 mol/L.
Preferably, the concentration of the chitosan rare earth complex solution prepared in the step S3 is 0.4-1 mol/L.
Preferably, the mass concentration of the aqueous polymer solution B in the step S4 is 0.5% -5%.
Preferably, the concentration of the polymer coated chitosan rare earth complex solution prepared in the step S4 is 0.05-0.5mol/L.
Preferably, the preparation method of the metal-based composite antibacterial liquid comprises the following steps:
adding the polymer-coated rare earth complex solution and the polymer-coated metal nanowire dispersion into a solvent, and stirring for 10-60min to obtain the metal-based composite antibacterial solution.
In a second aspect, the invention also provides the metal-based composite antibacterial liquid prepared by the preparation method.
In a third aspect, the invention also provides application of the metal-based composite antibacterial liquid in preparation of wound dressing, antibacterial coating or antibacterial spray. For example, the wound dressing can be prepared into a dressing for long-acting sterilization and antibiosis of wounds, and surgical articles such as bandages, absorption pads and the like can be prepared; the long-acting antibacterial coating is coated or sprayed on the surface of the special medical instrument, is used for cleaning the surface of the high-value medical instrument, and plays roles in sterilization and antibiosis; the method is applied to scenes with high environmental requirements (such as for patients with immunity deficiency), and is used for cleaning and sterilizing the environment.
Compared with the prior art, the invention has the following advantages:
The prepared metal-based composite antibacterial liquid is coated on the metal nanowire together with the polymer through the chitosan rare earth complex coated by the polymer, so that the metal-based composite antibacterial liquid becomes a composite antibacterial agent. The metal nanowire can avoid the risk of color change through the coating of the polymer, is favorable for forming an antibacterial network in an antibacterial layer, can form a larger antibacterial effective area by adopting lower use amount compared with the metal nanowire, and simultaneously cooperates with the chitosan rare earth complex, so that the antibacterial composite has the advantages of low cost, excellent antibacterial performance, long-acting antibacterial performance, excellent ageing resistance and the like, has the antibacterial efficiency of over 95 percent for escherichia coli and staphylococcus aureus, and has the advantages of low cost, no toxicity and harm, excellent antibacterial persistence and capability of effectively reducing the propagation and infection risk of bacteria.
Detailed Description
Unless defined otherwise, technical terms used in the following examples have the same meaning as commonly understood by one of ordinary skill in the art to which the inventive concepts pertain. The test reagents used in the following examples, unless otherwise specified, are all conventional biochemical reagents; the experimental methods are conventional methods unless otherwise specified.
Chitosan, purchased from henna Qianlu chemical products limited, has a deacetylation degree of >85% and a relative molecular mass of 1.8x10 6. The present invention will be described in detail with reference to examples.
Example 1
(1) Preparing a polymer coated metal nanowire dispersion: 100mg of silver nanowires were added to 100mL of 1% PVP in water and stirred at a rate of 200rad/min for 0.5h to give PVP-coated silver nanowire dispersion.
(2) Preparing chitosan solution: dispersing chitosan in pure water, heating to 60deg.C in water bath or oil bath, and magnetically stirring at 200rad/min for 10min to obtain chitosan solution with concentration of 0.1 mol/L.
(3) Preparing rare earth salt solution: cerium nitrate hydrate was dissolved in pure water to prepare a cerium nitrate solution of 0.6 mol/L.
(4) Preparing a chitosan rare earth complex solution: adding cerium nitrate solution into chitosan solution, vacuumizing (-0.1 MPa) and stirring for 1h at 60 ℃ to obtain chitosan rare earth complex solution with the concentration of 0.4 mol/L.
(5) Preparing a polymer coated chitosan rare earth complex solution: 12.5mL of the chitosan rare earth complex solution is dripped into 87.5mL of 1% PVP water solution, and stirring is carried out for 20min, thus obtaining 100mLPVP coated chitosan rare earth complex solution.
(6) Preparing a metal-based composite antibacterial solution: 3mL of PVP coated silver nanowire dispersion liquid and 0.2mLPVP coated chitosan rare earth complex solution are added into ethanol to be fixed to 1L and stirred for 20min, so as to prepare the cerium-silver based composite antibacterial liquid.
Example 2
(1) Preparing a polymer coated metal nanowire dispersion: 500mg of copper nanowires were added to 100mL of a 1.5% PVDF aqueous solution and stirred at 300rad/min for 1 hour to give a PVDF-coated copper nanowire dispersion.
(2) Preparing chitosan quaternary ammonium salt solution: dispersing chitosan quaternary ammonium salt in 50mL of pure water, heating to 70 ℃ in water bath or oil bath, and magnetically stirring at a speed of 200rad/min for 10min to prepare the chitosan quaternary ammonium salt solution with the concentration of 0.15 mol/L.
(3) Preparing rare earth salt solution: yttrium nitrate hydrate was dissolved in pure water to prepare a 0.75mol/L yttrium nitrate solution.
(4) Preparing a chitosan quaternary ammonium salt rare earth complex solution: adding yttrium nitrate solution into the aqueous solution dispersed with chitosan quaternary ammonium salt, and vacuumizing (-0.1 MPa) and stirring for 1.5h at 60 ℃ to obtain the solution of the chitosan quaternary ammonium salt rare earth complex with the concentration of 0.5 mol/L.
(5) Preparing a polymer coated chitosan rare earth complex solution: 20mL of chitosan quaternary ammonium salt rare earth complex solution is dripped into 80mL of 1.5% PVDF aqueous solution, and stirring is carried out for 35min, thus obtaining 100mL of PVDF coated chitosan rare earth complex solution.
(6) Preparing a metal-based composite antibacterial solution: adding 2mLPVDF of copper nanowire dispersion liquid coated with the coating and 1mLPVDF of chitosan quaternary ammonium salt rare earth complex solution into ethanol to fix the volume to 1L, and stirring for 30min to prepare yttrium-copper-based composite antibacterial liquid.
Example 3
(1) Preparing a polymer coated metal nanowire dispersion: 600mg of zinc nanowires were added to 100mL of an aqueous solution with 5% PVDF and stirred at 300rad/min for 1 hour to give a PVDF-coated copper nanowire dispersion.
(2) Preparing chitosan solution: dispersing chitosan quaternary ammonium salt in 100mL of pure water, heating to 70 ℃ in water bath or oil bath, and magnetically stirring at a speed of 200rad/min for 10min to prepare 0.2mol/L chitosan quaternary ammonium salt solution.
(3) Preparing rare earth salt solution: the samarium nitrate hydrate was dissolved in 50mL of pure water to prepare a 0.6mol/L samarium nitrate solution.
(4) Preparing a chitosan quaternary ammonium salt rare earth complex solution: adding samarium nitrate solution into aqueous solution dispersed with chitosan quaternary ammonium salt, vacuumizing (-0.1 MPa) and stirring for 1.5h at 60 ℃ to obtain 0.6mol/L chitosan quaternary ammonium salt rare earth complex solution.
(5) Preparing a polymer-coated chitosan quaternary ammonium salt rare earth complex solution: and (3) dropwise adding 50mL of the chitosan quaternary ammonium salt rare earth complex solution into 50mL of 1.5% PVDF aqueous solution, and stirring for 35min to obtain 100mL of PVDF-coated chitosan quaternary ammonium salt rare earth complex solution.
(6) Preparing a metal-based composite antibacterial solution: adding 3mLPVDF coated zinc nanowire dispersion liquid and 1mLPVDF coated chitosan quaternary ammonium salt rare earth complex solution into ethanol to fix the volume to 1L, and stirring for 30min to prepare the samarium-zinc-based composite antibacterial liquid.
Example 4
(1) Preparing a polymer coated metal nanowire dispersion: 800mg of silver nanowires were added to 100mL of an aqueous solution with 5% PVDF and stirred at a rate of 300rad/min for 1 hour to give a PVDF-coated silver nanowire dispersion.
(2) Preparing chitosan quaternary ammonium salt solution: dispersing chitosan quaternary ammonium salt in 30mL of pure water, heating to 70 ℃ in water bath or oil bath, and magnetically stirring at a speed of 200rad/min for 10min to prepare 0.25mol/L chitosan quaternary ammonium salt solution.
(3) Preparing rare earth salt solution: europium nitrate hydrate was dissolved in 20mL of pure water to prepare a europium nitrate solution of 0.7 mol/L.
(4) Preparing a chitosan quaternary ammonium salt rare earth complex solution: adding europium nitrate solution into aqueous solution dispersed with chitosan quaternary ammonium salt, and vacuumizing (-0.1 MPa) and stirring for 1.5h at 60 ℃ to obtain 0.8mol/L solution of chitosan quaternary ammonium salt rare earth complex.
(5) Preparing a polymer-coated chitosan quaternary ammonium salt rare earth complex solution: and (3) dropwise adding 50mL of the chitosan quaternary ammonium salt rare earth complex solution into 50mL of the 5% PVDF aqueous solution, and stirring for 35min to obtain 100mL of PVDF-coated chitosan quaternary ammonium salt rare earth complex solution.
(6) Preparing a metal-based composite antibacterial solution: adding 3mLPVDF of silver nanowire dispersion liquid coated with the coating and 1mLPVDF of chitosan quaternary ammonium salt rare earth complex solution into 1.5kg of ethanol, and stirring for 30min to prepare europium-silver matrix composite antibacterial liquid.
Example 5
(1) Preparing a polymer coated metal nanowire dispersion: 1000mg of silver nanowires were added to 100mL of an aqueous solution with 0.5% PVDF and stirred at a rate of 300rad/min for 1 hour to give a PVDF-coated silver nanowire dispersion.
(2) Preparing chitosan solution: dispersing chitosan quaternary ammonium salt in 200mL of pure water, heating to 70 ℃ in water bath or oil bath, and magnetically stirring at a speed of 200rad/min for 10min to prepare 0.3mol/L chitosan quaternary ammonium salt solution.
(3) Preparing rare earth salt solution: neodymium nitrate hydrate was dissolved in 100mL of pure water to prepare a neodymium nitrate solution of 0.8 mol/L.
(4) Preparing a chitosan quaternary ammonium salt rare earth complex solution: adding neodymium nitrate solution into the aqueous solution dispersed with chitosan quaternary ammonium salt, and vacuumizing (-0.1 MPa) and stirring for 1.5 hours at 60 ℃ to obtain 1mol/L chitosan quaternary ammonium salt rare earth complex solution.
(5) Preparing a polymer-coated chitosan quaternary ammonium salt rare earth complex solution: and (3) dropwise adding 50mL of the chitosan quaternary ammonium salt rare earth complex solution into 50mL of 0.5% PVDF aqueous solution, and stirring for 35min to obtain 100mL of PVDF-coated chitosan quaternary ammonium salt rare earth complex solution.
(6) Preparing a metal-based composite antibacterial solution: adding 3mLPVDF of silver nanowire dispersion liquid coated with the silver nanowire and 1mLPVDF of chitosan quaternary ammonium salt rare earth complex solution coated with the silver nanowire dispersion liquid into ethanol to fix the volume to 1L, and stirring for 30min to prepare neodymium-silver based composite antibacterial liquid.
Comparative example 1
(1) Preparing chitosan solution: dispersing chitosan in pure water, heating to 60deg.C in water bath or oil bath, and magnetically stirring at 200rad/min for 10min to obtain 0.1mol/L chitosan solution.
(2) Preparing rare earth salt solution: cerium nitrate hydrate was dissolved in 10mL of pure water to prepare a cerium nitrate solution of 0.6 mol/L.
(3) Preparing a chitosan rare earth complex solution: 10mL of cerium nitrate solution is added into 60mL of chitosan aqueous solution, and the mixture is vacuumized (-0.1 MPa) and stirred for 1 hour at 60 ℃ to obtain 70mL of 0.4mol/L chitosan rare earth complex solution.
(4) Preparing a polymer coated chitosan rare earth complex solution: 12.5mL of the chitosan rare earth complex solution is dripped into 97.5mL of 1% PVP water solution, and stirring is carried out for 20min, thus obtaining 100mLPVP coated chitosan rare earth complex solution.
(5) Preparing a metal-based composite antibacterial solution: adding 3mLPVP of silver nanowire dispersion liquid coated with the coating and 0.2mLPVP of chitosan rare earth complex solution into ethanol, fixing the volume to 1L, and stirring for 20min to prepare Cheng Shiji composite antibacterial liquid.
Comparative example 2
(1) Preparing a polymer coated metal nanowire dispersion: 100mg of silver nanowires were added to 100mL of 1% PVP in water and stirred at a rate of 200rad/min for 0.5h to give 100mL of PVP-coated silver nanowire dispersion having a concentration of 1 g/L.
(2) Adding the silver nanowire dispersion liquid coated by 2mLPVP into 1kg of ethanol, and stirring for 20min to prepare the composite antibacterial liquid.
Comparative example 3
The cerium-silver-based composite antibacterial solution in this comparative example is different from the preparation method of example 1 in that the same amount of silver nanoparticles is used instead of silver nanowires, and other parameters, ratios and processes are the same.
Comparative example 4
The cerium-silver-based composite antibacterial solution in this comparative example is different from the preparation method of example 1 in that the addition amount of the PVP coated silver nanowire dispersion solution is 31mL, and other proportions and parameters are the same.
Comparative example 5
The cerium-silver-based composite antibacterial solution in this comparative example is different from the preparation method of example 1 in that the PVP-coated silver nanowire dispersion in step (6) is added in an amount of 2mL, and the other ratios and parameters are the same.
Comparative example 6
The cerium-silver-based composite antibacterial solution in the comparative example is different from the preparation method of example 1 in that the PVP coated chitosan rare earth complex solution in the step (6) is added in an amount of 0.18mL, and other proportions and parameters are the same.
Comparative example 7
The cerium-silver-based composite antibacterial solution in the comparative example is different from the preparation method of the example 1 in that the PVP coated chitosan rare earth complex solution in the step (6) is added in an amount of 11mL, and other proportions and parameters are the same.
Bacteriostasis test:
And (3) dropwise adding 100 mu L of the prepared bacterial suspension into each test tube of the tested sample liquid and the test tube of the control sample liquid respectively by using 4 tubes of the antibacterial liquid and the control sample liquid prepared in the examples 1-5 and the comparative examples 1-7, uniformly mixing, taking the reaction time of 2min, 5min, 10min and 20min, then taking 0.5mL of the sample liquid, putting into the test tube containing 5mLPBS, fully mixing, properly diluting, pouring into a plate, culturing, and counting viable bacterial colonies.
The calculation formula of the bacteriostasis rate is as follows:
The test results are shown in the following table:
table 1 results of bacteriostasis rates of examples 1 to 5
TABLE 2 results of comparative examples 1-7 antibacterial rate
Remarks: the negative control group had no bacterial growth.
As can be seen from the table, the antibacterial performance of the antibacterial liquid is obviously superior to that of the chitosan rare earth complex alone, the metal nanowire alone, the metal nanoparticle and the content of the metal nanowire in the antibacterial liquid are lower than or higher than 3-30mg/L, and the concentration of the chitosan rare earth complex is lower than or higher than 0.00001-0.0005mol/L, because the chitosan rare earth complex is coated on the metal nanowire, the composite antibacterial agent is formed, the functions and advantages of the composite antibacterial agent are complementarily enhanced, and the relatively excellent antibacterial performance and the excellent long-acting antibacterial and aging-resistant performances are realized. If the content of the metal nano wire is too high, agglomeration phenomenon can be generated, a uniform antibacterial network can not be formed, so that the antibacterial effect is seriously affected, and meanwhile, the cost is greatly increased; too low a metal nanowire content does not form an antibacterial network. If the content of the chitosan rare earth complex is too high, the release of the antibacterial property of the metal nanowire can be greatly slowed down, and if the content is too low, the antibacterial effect of the slow-release metal nanowire can not be achieved, the antibacterial time of the antibacterial liquid can not be prolonged, and the aging resistance can be reduced.
The above embodiments are merely preferred embodiments of the present invention and are not intended to limit the present invention, and any modifications, equivalent substitutions, improvements, etc. within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (7)
1. A metal-based composite antibacterial solution is characterized in that: the metal-based composite antibacterial liquid is prepared from polymer-coated metal nanowire dispersion liquid, polymer-coated chitosan rare earth complex solution and a solvent, wherein the content of the metal nanowire in the metal-based composite antibacterial liquid is 3-30mg/L, and the concentration of the chitosan rare earth complex in the metal-based composite antibacterial liquid is 0.00001-0.0005mol/L;
The metal nanowire is one or a combination of at least two of a silver nanowire, a copper nanowire and a zinc nanowire;
The polymer is one or the combination of at least two of polyvinylpyrrolidone, hydroxypropyl cellulose, sodium hydroxypropyl cellulose, polyvinylidene fluoride and polyacrylic acid;
the chitosan rare earth complex is synthesized by reacting rare earth salt with chitosan or chitosan quaternary ammonium salt;
The cation of the rare earth salt comprises any one or a combination of at least two of cerium ions, lanthanum ions, yttrium ions, samarium ions, europium ions and neodymium ions; the anions of the rare earth salt are any one or a combination of at least two of nitrate ions, chloride ions, sulfate ions and acetate ions.
2. The metal-based composite antibacterial liquid according to claim 1, wherein: the preparation method of the polymer-coated metal nanowire dispersion liquid comprises the following steps:
Dissolving a polymer in water to obtain a polymer water solution A, adding the metal nanowire into the polymer water solution A, and stirring for 0.5-4h at the rotating speed of 50-500rad/min to obtain a polymer coated metal nanowire dispersion.
3. The metal-based composite antibacterial liquid according to claim 2, wherein: the concentration of the metal nanowires in the polymer coated metal nanowire dispersion liquid is 1-10g/L; the mass concentration of the polymer aqueous solution A is 0.5% -5%.
4. The metal-based composite antibacterial liquid according to claim 1, wherein: the preparation method of the polymer-coated chitosan rare earth complex solution comprises the following steps:
S1: dispersing chitosan or chitosan quaternary ammonium salt in pure water, heating to 50-80 ℃, and stirring for 0.1-2h at a rotating speed of 50-500rad/min to obtain chitosan solution;
s2: dissolving rare earth salt hydrate in pure water to prepare rare earth salt solution;
S3: dropwise adding the rare earth salt solution into the chitosan solution, and stirring for 0.5-4h at 50-80 ℃ under vacuum condition to obtain a chitosan rare earth complex solution;
s4: and (3) dropwise adding the chitosan rare earth complex solution into the polymer aqueous solution B, and stirring for 10-60min at normal temperature to obtain the polymer-coated chitosan rare earth complex solution.
5. The metal-based composite antibacterial liquid according to claim 4, wherein:
the concentration of the chitosan solution prepared in the step S1 is 0.05-0.3mol/L;
the concentration of the rare earth salt solution prepared in the step S2 is 0.3-0.8mol/L;
The concentration of the chitosan rare earth complex solution prepared in the step S3 is 0.4-1mol/L;
the mass concentration of the polymer aqueous solution B in the step S4 is 0.5% -5%;
The concentration of the polymer coated chitosan rare earth complex solution prepared in the step S4 is 0.05-0.5mol/L.
6. The metal-based composite antibacterial liquid according to claim 1, wherein: the preparation method of the antibacterial liquid comprises the following steps:
adding the polymer-coated rare earth complex solution and the polymer-coated metal nanowire dispersion into a solvent, and stirring for 10-60min to obtain the metal-based composite antibacterial solution.
7. Use of a metal matrix composite antiseptic solution according to any one of claims 1-6 for the preparation of a wound dressing, an antiseptic coating or an antiseptic spray.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410641845.2A CN118267508B (en) | 2024-05-23 | 2024-05-23 | Metal-based composite antibacterial liquid and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410641845.2A CN118267508B (en) | 2024-05-23 | 2024-05-23 | Metal-based composite antibacterial liquid and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN118267508A CN118267508A (en) | 2024-07-02 |
CN118267508B true CN118267508B (en) | 2024-08-09 |
Family
ID=91640146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410641845.2A Active CN118267508B (en) | 2024-05-23 | 2024-05-23 | Metal-based composite antibacterial liquid and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118267508B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101851258A (en) * | 2009-04-01 | 2010-10-06 | 中国科学院大连化学物理研究所 | Chitosan oligosaccharide-rare earth complexes and preparation and application |
CN101962532A (en) * | 2010-09-21 | 2011-02-02 | 东华大学 | Method for synthesizing polyacrylic acid (PAA)-coated rare earth fluoride functionalized nanomaterial by in-situ polymerization |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102487963B (en) * | 2011-12-07 | 2013-10-30 | 聊城大学 | Agricultural bactericide containing rare-earth elements and chitosan and/or derivatives of chitosan |
CN103242594B (en) * | 2013-05-14 | 2015-08-05 | 中国科学院长春应用化学研究所 | Polyalcohol hydrogel microballoon and preparation method thereof |
CN103726319B (en) * | 2013-12-09 | 2017-01-04 | 科凯精细化工(上海)有限公司 | A kind of chitosan loaded nanometer titanium dioxide compound and preparation method thereof |
CN104999072B (en) * | 2015-06-29 | 2017-09-26 | 南京宜洛辞电子科技有限公司 | A kind of redispersible nano silver wire mixture and preparation method thereof |
CN116236611B (en) * | 2023-05-09 | 2023-08-01 | 天津包钢稀土研究院有限责任公司 | Rare earth metal-based functional interactive dressing and preparation method thereof |
-
2024
- 2024-05-23 CN CN202410641845.2A patent/CN118267508B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101851258A (en) * | 2009-04-01 | 2010-10-06 | 中国科学院大连化学物理研究所 | Chitosan oligosaccharide-rare earth complexes and preparation and application |
CN101962532A (en) * | 2010-09-21 | 2011-02-02 | 东华大学 | Method for synthesizing polyacrylic acid (PAA)-coated rare earth fluoride functionalized nanomaterial by in-situ polymerization |
Also Published As
Publication number | Publication date |
---|---|
CN118267508A (en) | 2024-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109735154B (en) | Long-acting antibacterial agent, long-acting antibacterial agent with immediate effect and preparation method thereof | |
CN107951902B (en) | Graphene antibacterial composition and sanitary material using same | |
CN109481731A (en) | A kind of nano-oxide/kaolin compound hemostatic anti-biotic material, functions of stanching and promoting healing dressing and preparation method thereof | |
CN101633045B (en) | Nanometer silver collodol, preparation method and application thereof | |
CN109880470B (en) | Preparation method of water-based acrylate time-delay antibacterial coating | |
CN111185170B (en) | Preparation method of nano-silver antibacterial composite material wrapped by nano-zinc oxide | |
CN106810800B (en) | A kind of preparation method of antibiotic property polyvinyl alcohol/nanocrystalline cellulose-graphene oxide PVA/CNC-GO composite membrane | |
CN103798289A (en) | Preparation method of silver-loaded mesoporous silicon dioxide antibacterial agent | |
CN101508863B (en) | Nano-hydroxyapatite antimicrobial paint and method for producing the same | |
CN103783079A (en) | Preparation method of silver-loaded mesoporous inorganic antibacterial agent | |
CN101731272A (en) | Method for preparing antibacterial nanometer silver colloid | |
CN1784973A (en) | Method for preparing composite photocatalytic germicide | |
CN112136829B (en) | Preparation of porous graphene-loaded weak photocatalyst-nano silver composite antiviral powder | |
CN110547302B (en) | Antibacterial powder and preparation method and application thereof | |
CN101669520A (en) | Air conditioning filter screen bacteriostatic agent and preparation method thereof as well as preparation method of air conditioning filter screen | |
CN104855380A (en) | Preparation method of antibacterial metal-organic framework membrane | |
CN110063340A (en) | One kind mixing silver-colored nano titania antibacterial agent and preparation method thereof | |
CN105498558A (en) | Hybrid membrane loaded with silver nanoparticles and preparation method and application thereof | |
CN112795098A (en) | Antibacterial plastic and preparation method thereof | |
CN1784974A (en) | Composite photocatalitic germicide | |
CN113718522B (en) | Long-acting antibacterial composition and preparation method thereof | |
CN111676695A (en) | Dual-antibacterial non-woven fabric and preparation method thereof | |
CN118267508B (en) | Metal-based composite antibacterial liquid and preparation method and application thereof | |
CN113261566B (en) | Preparation method of basic magnesium hypochlorite loaded metal organic framework bacteriostatic agent | |
CN1295965C (en) | Inorganic mesoporous antiseptic material and its preparing method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |